Therapeutic advances in the targeting of ROR1 in hematological cancers
Sign Up to like & getrecommendations! Published in 2024 at "Cell Death Discovery"
DOI: 10.1038/s41420-024-02239-1
Abstract: Receptor tyrosine kinases (RTKs) are key cell surface receptors involved in cell communication and signal transduction, with great importance in cell growth, differentiation, survival, and metabolism. Dysregulation of RTKs, such as EGFR, VEGFR, HER2 or… read more here.
Keywords: targeting ror1; therapeutic advances; advances targeting; ror1 hematological ... See more keywords